What did ADDvise Group AB pay for Surplus Diabetic?

ADDvise Group AB acquired Surplus Diabetic for $15.8M in 2023 (5.9x EBITDA), equivalent to 2.30x revenue. Target revenue was approximately $7.0M. Target EBITDA was approximately $2.7M.

What does Surplus Diabetic do?

Surplus Diabetic is a durable medical equipment business.

What multiple did ADDvise Group AB pay for Surplus Diabetic?

5.9x EBITDA and 2.30x revenue, based on disclosed deal value of $15.8M and disclosed financials.

M&A TRANSACTION · 2023

Surplus Diabetic acquired by ADDvise Group AB

$15.8M· 5.9x EBITDA· 2.30x revenue

Target

Surplus Diabetic

Acquirer

ADDvise Group AB

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$7.0M

EBITDA

$2.7M

Deal Value

$15.8M

EV/EBITDA

5.9x

Context

This $15.8M acquisition of Surplus Diabetic by ADDvise Group AB sits in the durable medical equipment sub-vertical. The 5.9x EBITDA multiple paid in 2023 can be compared against the population median for durable medical equipment transactions of similar size on our Durable Medical Equipment valuation hub. ADDvise Group AB is acquiring as a strategic buyer; see how strategic acquirers typically price durable medical equipment businesses on our Durable Medical Equipment strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own durable medical equipment

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Surplus Diabetic acquisition.

Citation: ExitValue.ai. (2023). Surplus Diabetic acquired by ADDvise Group AB. https://exitvalue.ai/deals/surplus-diabetic-acquired-by-addvise-group-ab-hc-2023-0051